Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current pharmacological treatments for COVID‐19: What's next?
Cristina Scavone, Simona Brusco, Michele Bertini, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 21, pp. 4813-4824
Open Access | Times Cited: 268

Showing 1-25 of 268 citing articles:

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
W. Joost Wiersinga, Andrew Rhodes, Allen C. Cheng, et al.
JAMA (2020) Vol. 324, Iss. 8, pp. 782-782
Closed Access | Times Cited: 4342
Shermo: A general code for calculating molecular thermochemistry properties
Tian Lu, Qinxue Chen
Computational and Theoretical Chemistry (2021) Vol. 1200, pp. 113249-113249
Open Access | Times Cited: 662
The COVID-19 pandemic and physical activity
Jeffrey A. Woods, Noah T. Hutchinson, Scott K. Powers, et al.
Sports Medicine and Health Science (2020) Vol. 2, Iss. 2, pp. 55-64
Open Access | Times Cited: 595
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
José L. Pablos, María Galindo, Loreto Carmona, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 12, pp. 1544-1549
Open Access | Times Cited: 226
The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options
Shalki Choudhary, Kajal Sharma, Om Silakari
Microbial Pathogenesis (2020) Vol. 150, pp. 104673-104673
Open Access | Times Cited: 194
Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future
Olayinka O. Ogunleye, Debashis Basu, Debjani Mueller, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 191
SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells
Michihito Sasaki, Kentaro Uemura, Akihiko Sato, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 1, pp. e1009233-e1009233
Open Access | Times Cited: 190
Global data analysis and risk factors associated with morbidity and mortality of COVID-19
Sina Salajegheh Tazerji, Fatemeh Shahabinejad, Mahya Tokasi, et al.
Gene Reports (2022) Vol. 26, pp. 101505-101505
Open Access | Times Cited: 76
An overview on the treatments and prevention against COVID-19
Yunes Panahi, Armita Mahdavi Gorabi, Sona Talaei, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 48
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review
Wei Feng, Wei Zong, Feng Wang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 134
Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease
Emanuelle Machado Marinho, João Batista de Andrade Neto, Jacilene Silva, et al.
Microbial Pathogenesis (2020) Vol. 148, pp. 104365-104365
Open Access | Times Cited: 133
Curcumin, a traditional spice component, can hold the promise against COVID-19?
Vivek Kumar Soni, Arundhati Mehta, Yashwant Kumar Ratre, et al.
European Journal of Pharmacology (2020) Vol. 886, pp. 173551-173551
Open Access | Times Cited: 113
Green micellar solvent-free HPLC and spectrofluorimetric determination of favipiravir as one of COVID-19 antiviral regimens
Ibraam E. Mikhail, Heba Elmansi, Fathalla Belal, et al.
Microchemical Journal (2021) Vol. 165, pp. 106189-106189
Open Access | Times Cited: 99
Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives
Chandan Kumar Sarkar, Milon Mondal, Muhammad Torequl Islam, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 94
Covid-19 Kills More Men Than Women: An Overview of Possible Reasons
Annalisa Capuano, Francesco Rossi, Giuseppe Paolisso
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 93
Emerging agents and regimens for hepatocellular carcinoma
Xiao‐Dong Zhu, Hui‐Chuan Sun
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 91
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic
Anne‐Marie C. Dingemans, Ross A. Soo, Abdul Rahman Jazieh, et al.
Journal of Thoracic Oncology (2020) Vol. 15, Iss. 7, pp. 1119-1136
Open Access | Times Cited: 91
Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure–Activity Relationship, and X-ray Structural Studies
Arun K. Ghosh, Jakka Raghavaiah, Dana Shahabi, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 19, pp. 14702-14714
Open Access | Times Cited: 80
Prospects for RNAi Therapy of COVID-19
Hasan Uludağ, Kylie Parent, Hamidreza Montazeri Aliabadi, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 79
Animal models for SARS‐CoV‐2 research: A comprehensive literature review
Kabita Pandey, Arpan Acharya, Mahesh Mohan, et al.
Transboundary and Emerging Diseases (2020) Vol. 68, Iss. 4, pp. 1868-1885
Open Access | Times Cited: 73
nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics
Md. Tanvir Kabir, Md. Sahab Uddin, Md. Farhad Hossain, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 70
Silver nanoparticles as a potential treatment against SARS‐CoV‐2: A review
Fernanda Pilaquinga, Jeroni Morey, Marbel Torres Arias, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2021) Vol. 13, Iss. 5
Open Access | Times Cited: 67
Recent advancements of organotin(IV) complexes derived from hydrazone and thiosemicarbazone ligands as potential anticancer agents
Jai Devi, Binesh Kumar, Bharti Taxak
Inorganic Chemistry Communications (2022) Vol. 139, pp. 109208-109208
Closed Access | Times Cited: 65
Two Green Micellar HPLC and Mathematically Assisted UV Spectroscopic Methods for the Simultaneous Determination of Molnupiravir and Favipiravir as a Novel Combined COVID-19 Antiviral Regimen
Yasmine Ahmed Sharaf, Sami El Deeb, Adel Ehab Ibrahim, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2330-2330
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top